TICKER: MSSV
(800) 956-3935
Industry News
2023 Year in Review
2024 Forecast and Outlook [MSSV]
January 30, 2024 / Source
2023 fiscal year with approximately $2.4 million in sales, a more than 50% increase over 2022 levels. Sales were derived from its 4 main channels, Training, Product sales, Equipment sales and Patient procedures. The Company expects to reach $5 million in revenues with approximately $1 million in operating profits [more]
Announcement to Change Name [MSSV]
February 5, 2024 / Source
Numismatics Inc., a regenerative medicine company is pleased to announce that it will be undergoing a name change from Meso Numismatics Inc. to Regenerative Medical Technology Group Inc. to better reflect the company’s business. The Company currently has a network of 26 clinics in 21 countries that carry its banner and has its own clinic in Cancun and is currently building another one in Dubai. [more]
Global Stem Cell Collaboration Announcement
GSCG - Stembio / Source
The best experts in the field of regenerative medicine, which aims to chance, repair or regenerate human or animal cells, tissues or organs to restore damaged tissues or organs due to various reasons such as disease, trauma, or congenital issues, gathered at the World Regenerative Medicine Congress held in Istanbul. [more]
Artificial cartilage with the help of 3D printing
Science Daily / Source
A special high-resolution 3D printing process is used to create tiny, porous spheres made of biocompatible and degradable plastic, which are then colonized with cells. These spheroids can then be arranged in any geometry, and the cells of the different units combine seamlessly to form a uniform, living tissue.
Stem Cell Therapy Market Assessment
Global Market Insights / Source
The stem cell therapy market is expected to grow from $11.2 billion in 2022 to $31.4 billion by 2030 according to Precedence Research. The Company has also entered the exosome market, which is expected to grow from $250 million in 2022 to $3.2 billion by 2032 according to Global Market Insights.
Regenerative Medicine Market Size & Share Analysis
Mordor Intelligence / Source
The stem cell therapy market is expected to grow from $11.2 billion in 2022 to $31.4 billion by 2030 according to Precedence Research. The Company has also entered the exosome market, which is expected to grow from $250 million in 2022 to $3.2 billion by 2032 according to Global Market Insights.
Follow Us
We are an SEC reporting company that trades on the OTC Markets. With millions of people worldwide suffering from a variety of physical and aesthetic conditions and chronic illnesses, RMTG has embarked upon a bold commitment, dedicating our company resources and efforts into an exciting, global growth market of regenerative medicine technologies.
More
© Copyright 2024. Regenerative Medical Technology Group Inc. All rights reserved.